In particular, local in vivo microinjection of clodronate liposomes into SGs simultaneously inhibits CHF-induced elevation of TNFα and IL-1β, increases in N-type Ca2+ currents, and cardiac sympathetic overactivation. Here, TNF is linked to congestive heart failure.